10 reasons digital strategies fail plus ways you and your teams can navigate between the icebergs of these failures on the way to success.
This MAPS Executive Consortium article explores ways in which Medical Affairs can help industry adapt its practices to deal with emerging issues in the transition to personalized medicine.
This webinar aims to explore and provide a nuanced understanding of Innovative Medical Affairs roles within the pharmaceutical industry for critical evaluation by the Medical Affairs community, including new “Hybrid Medical Science Liaison (MSL)” roles ranging from business savvy to more commercial oriented MSLs.
This webinar provides the Medical Affairs community with a differentiated and bold view to drive the future state of Medical Affairs and what “good” looks like regarding the role of Medical Affairs in Clinical Development.
It’s time to move omnichannel from discussion to reality using the steps: Observe, Plan, Engage and Nurture.
This article discusses how to foster innovation within and across the Medical Affairs landscape, empower teams to deliver the best outcomes for patients and revolutionize healthcare delivery.
Join the MAPS Med Tech FAWG as they discuss “Medical Affairs Mastery: Shaping the Future of MedTech with MAPS”!
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
In this webinar, our panelists highlight key areas of the Standards and Guidance created between MAPS, phactMI & MILE and how to use this S&G to move to a best-in-class medical information organization.
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations.